Clinical Trial Details

< Previous Trial     Next Trial >
Study ID CDR0000669342
Investigator
Jie Deng, RN, BSN, MSN,   Vanderbilt-Ingram Cancer Center
Title Impact of Secondary Lymphedema on Symptoms, Functional Status, and Quality of Life After Treatment in Patients With Head and Neck Cancer
Conditions Cancer Survivor
Head and Neck Cancer
Lymphedema
Interventions
Phase Phase 1
Purpose RATIONALE: Collecting information about the impact of lymphedema on symptoms, functional status, and quality of life after treatment in patients with head and neck cancer may help doctors learn more about the disease and plan the best treatment. PURPOSE: This phase I trial is studying the effects of secondary lymphedema on symptoms, functional status, and quality of life after treatment in patients with head and neck cancer.
Eligibility Ages Eligible: 18 Years
Genders Eligible:  Both
Accepts Healthy Volunteers:  No
DISEASE CHARACTERISTICS:
  • Diagnosed with head and neck cancer
  • At least 3 months since completion of head and neck cancer treatment
  • Participating in the Pain and Symptom Management Program at the Vanderbilt-Ingram Cancer Center
  • No current evidence of cancer
  • No metastatic disease PATIENT CHARACTERISTICS:
  • No other active cancer
  • Able to understand informed consent PRIOR CONCURRENT THERAPY:
  • See Disease Characteristics
  • No concurrent chemotherapy or radiotherapy
  • Study Location
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee, 37232-6838
    Contact N/A

    Information objtained from ClinicalTrials.gov, on 10/24/2014. For additional information about this and other clinical trials, visit http://clinicaltrials.gov.
    Please refer to this study by its ClinicalTrials.gov identifier: NCT01098669


    Back to Search Results